Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELI LILLY & CoLLY · Entity 2794 | Director | November 20, 2017 | November 22, 2017 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELI LILLY & Co
Report date November 20, 2017 · Filed November 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 36,284 |
Reported balance
After 2017-11-20 transaction · row 1
1 source rowRow 1 · 2017-11-20 · Grant · Acquired 1,924 · Balance 36,284 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 1,500 |
Reported balance
Holding disclosure · report date 2017-11-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 1,500 F1: Revocable Trust of which reporting person's spouse is the trustee. |
Filing footnotes · ownership attribution and instrument terms
F1: Revocable Trust of which reporting person's spouse is the trustee.
Elanco Animal Health Inc
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,451 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 111,451 F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 150,000 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 150,000 |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 15,920 |
Reported balance
Holding disclosure · report date 2026-05-21 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 15,920 |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BALL Corp
Report date April 25, 2018 · Filed April 25, 2018
Section 16 reporting ended · disclosed 2018-04-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 192,811.0889 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 192,811.0889 |
| Common StockSEC Table I · non-derivative | IndirectRDH Trust | 971,090 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 971,090 |
| Deferred Compensation Company Stock PlanSEC Table II · derivative / convertible security | Direct | 11,152.1288 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 11,152.1288 F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan. F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 38,542 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 38,542 F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock. |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $10.02 · Expires 2019-01-28 | Direct | 800,000 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 800,000 |
| Stock Appreciation Rights (sars)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 516,400 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 516,400 |
| Stock Option (iso) (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $12.61 · Expires 2020-01-27 | Direct | 13,600 |
Reported balance
Holding disclosure · report date 2018-04-25 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 13,600 |
Filing footnotes · ownership attribution and instrument terms
F1: Each unit may be settled for a single share of stock or the equivalent amount of cash pursuant to the Ball Corporation Deferred Compensation Company Stock Plan.
F2: Stock units in Ball Corporation's Deferred Compensation Company Stock Plan are distributed upon the separation of service in accordance with the Plan.
F3: Each restricted stock unit represents a contingent right to receive one share of Ball Corporation Common Stock.
EDGEWELL PERSONAL CARE Co
Report date February 03, 2021 · Filed February 05, 2021
Section 16 reporting ended · disclosed 2021-02-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 46,724 |
Reported balance
After 2021-02-03 transaction · row 1
1 source rowRow 1 · 2021-02-03 · Exercise / conversion · Acquired 20,839 · Balance 46,724 F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock EquivalentsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-02-03 · Other · Disposed 10,000 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-3-2017SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-02-03 · Other · Disposed 1,667 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 1-2-2018SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-03 · Other · Disposed 2,072 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-1-2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-03 · Other · Disposed 3,156 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Restricted Stock Equivalents 2-6-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-02-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-02-03 · Other · Disposed 3,944 · Balance 0 F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021. |
| Common StockSEC Table I · non-derivative | IndirectSuzanne A. Hoover Revocable Trust | 10,000 |
Reported balance
Holding disclosure · report date 2021-02-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 10,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Total of the previously deferred Restricted Stock Equivalents as reported here in Table II converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
F2: Previously deferred Restricted Stock Equivalents converted into shares of Edgewell common stock due to Mr. Hoover's retirement from the Board of Directors on February 3, 2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2011 Filed Apr 4, 2011 17:21 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 250 | $34.38 | $8,595.00 |
DisclosureSEC source: 0001209191-11-020875 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,155 Read SEC document |
| February 28, 2011 Filed Mar 2, 2011 18:21 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 249 | $34.43 | $8,573.07 |
DisclosureSEC source: 0001209191-11-014224 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,755 Read SEC document |
| January 31, 2011 Filed Feb 2, 2011 17:41 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 247 | $34.79 | $8,593.13 |
DisclosureSEC source: 0001209191-11-006279 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,506 Read SEC document |
| November 30, 2010 Filed Dec 1, 2010 15:03 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,187 | $34.63 | $144,995.81 |
DisclosureSEC source: 0001209191-10-057434 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,175 Read SEC document |
| December 31, 2009 Filed Jan 4, 2010 20:09 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 212 | $36.24 | $7,682.88 |
DisclosureSEC source: 0001209191-10-000185 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,748 Read SEC document |
| November 30, 2009 Filed Dec 1, 2009 21:09 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 4,040 | $35.89 | $144,995.60 |
DisclosureSEC source: 0001209191-09-054806 · doc4.xml · nonDerivative · entry 2 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,519 Read SEC document |
| November 30, 2009 Filed Dec 1, 2009 21:09 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 214 | $35.89 | $7,680.46 |
DisclosureSEC source: 0001209191-09-054806 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,479 Read SEC document |
| October 30, 2009 Filed Nov 2, 2009 14:26 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 246 | $35.28 | $8,678.88 |
DisclosureSEC source: 0001209191-09-050336 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,265 Read SEC document |
| September 30, 2009 Filed Sep 30, 2009 13:33 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 294 | $32.86 | $9,660.84 |
DisclosureSEC source: 0001209191-09-046080 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,019 Read SEC document |
| August 31, 2009 Filed Aug 31, 2009 14:02 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 234 | $32.71 | $7,654.14 |
DisclosureSEC source: 0001209191-09-042516 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 718 Read SEC document |
| July 31, 2009 Filed Aug 3, 2009 15:16 UTC | ELI LILLY & Co LLY · Entity 2794 | GrantCommon Stock | 484 | $33.72 | $16,320.48 |
DisclosureSEC source: 0001209191-09-038481 · doc4.xml · nonDerivative · entry 1 HOOVER R DAVID · CIK 0001186033 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 484 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.